Skip to content

+201111271919

Info@peakypaws.net

Enjoy free delivery on orders over 2,000 EGP, with same-day delivery in Sheikh Zayed and 6th of October.

Search Products

Bravecto 40-56 kg
Bravecto 40-56 kg

Bravecto 40-56 kg

Regular price LE 3,000.00


/
Only 5 left - Selling fast
Estimated delivery: Same day in El Sheikh Zayed & 6th of October City

Bravecto 40-56 kg

LE 3,000.00

1 Tablet
  • 1 Tablet

Bravecto 40-56 kg

Product Description

Bravecto 1400 mg Chewable Tablet for Extra Large Dogs (40–56 kg)

Product Overview
Bravecto is a veterinary prescription (POM-V) chewable tablet for extra large dogs weighing between 40 kg and 56 kg . Manufactured by MSD Animal Health (Merck Animal Health), it provides long-lasting protection against fleas, ticks, and mites with a single dose .

Key Specifications

Feature Details
Active Ingredient Fluralaner 1400 mg
Target Weight Range 40 – 56 kg (Extra Large Dogs)
Dosage Form Chewable Tablet (liver-flavored) 
Legal Category POM-V (Prescription Only Medicine – Veterinarian)
Duration of Protection 12 weeks (3 months) for fleas and most ticks
Minimum Age 8 weeks 
Minimum Weight 2 kg 
Manufacturer MSD Animal Health (Merck)

Key Benefits



Benefit Description
Long-Lasting Protection One chew provides 12 weeks of flea and tick protection—nearly 3 times longer than monthly treatments. Treat only 4 times per year for year-round protection .
Fast-Acting Starts killing fleas within 2 hours of administration, with >95% of fleas killed within 12 hours and >90% of ticks killed within 12 hours of attachment .
Waterproof & Convenient As an oral tablet, effectiveness is not affected by bathing, swimming, or rain—unlike topical spot-on treatments .
Breaks the Flea Life Cycle Kills fleas before they can lay viable eggs, effectively controlling environmental flea populations in areas to which the dog has access .
Highly Palatable Liver-flavored chew that most dogs readily accept as a treat. In a field study, 80.7% of dogs voluntarily consumed the tablet within 5 minutes .
Safe for Breeding Dogs Can be used in breeding, pregnant, and lactating dogs .

Indications for Use

Bravecto is indicated for the treatment and prevention of :



Parasite Type Specific Parasites
Fleas Ctenocephalides felisCtenocephalides canis
Ticks (12 weeks) Dermacentor variabilis (American dog tick), Haemaphysalis longicornis (Asian longhorned tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), Ixodes ricinusIxodes hexagonusDermacentor reticulatus
Mites Demodex spp. (demodicosis), Sarcoptes spp. (sarcoptic mange), Otodectes spp. (ear mites)

Additional Indications:

  • Can be used as part of a treatment strategy for Flea Allergy Dermatitis (FAD) 

  • Reduces the risk of Babesia canis (babesiosis) transmission by ticks 

  • Prevents Dipylidium caninum (tapeworm) transmission from infected fleas for 3 months 


Dosage and Administration



Dog Weight Tablet Strength Package Color 
2 – 4.5 kg 112.5 mg Yellow
> 4.5 – 10 kg 250 mg Orange
> 10 – 20 kg 500 mg Green
> 20 – 40 kg 1000 mg Blue
40 – 56 kg 1400 mg Pink

Administration Instructions:

  • Administer orally with food for maximum effectiveness (food increases bioavailability) 

  • The chewable tablet should not be broken or divided

  • Can be mixed with food or given by hand

  • Dogs over 56 kg should receive a combination of tablets that most closely matches body weight 


Safety Information

Contraindications:

  • Do not use in puppies less than 8 weeks of age or weighing less than 2 kg 

  • Do not use in case of hypersensitivity to fluralaner or any excipients 

Warnings and Precautions:

  • Use with caution in dogs with a history of seizures or neurological disorders 

  • Fluralaner belongs to the isoxazoline class, which has been associated with neurological adverse reactions including tremors, ataxia, and seizures 

  • Do not administer at intervals shorter than 8 weeks 

  • Fleas and ticks must attach to the host and commence feeding to be exposed to the active substance 


Adverse Reactions

Common adverse reactions observed in clinical field studies :



Frequency Adverse Reactions
Common (≥1%) Vomiting (7.1%), Decreased appetite (6.7%), Lethargy (5.4%), Diarrhea (4.9%)
Rare (<0.01%) Convulsions, ataxia, muscle tremor, pruritus, alopecia, hypersalivation, hemorrhagic diarrhea

Most reported adverse reactions were self-limiting and of short duration .


Storage Instructions

  • Store at or below 30°C in a cool, dry place 

  • Keep in the original packaging to protect from light

  • Keep out of reach of children, uninformed persons, and pets

Recommended Products
Add notes for your order
Coupon Code